Live Breaking News & Updates on Alexandra Weingarten

Stay updated with breaking news from Alexandra weingarten. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Kura Oncology to Report First Quarter 2024 Financial Results - Kura Oncology (NASDAQ:KURA)

SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) Kura Oncology, Inc. (NASDAQ:KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today ....

Alexandra Weingarten , Corporate Communications , Kura Oncology Inc , Vice President , Investor Relations ,

Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML

– Ziftomenib is the first investigational treatment to be granted Breakthrough Therapy Designation for NPM1-mutant AML – – Registration-directed trial of ziftomenib in NPM1-mutant AML on track. ....

Alexandra Weingarten , Troy Wilson , Kura Oncology Inc , Drug Administration , Globenewswire Inc , Exchange Commission , Corporate Communications , Breakthrough Therapy Designation , Chief Executive Officer , Orphan Drug Designation , Vice President , Investor Relations , Breakthrough Therapy ,

Kura Oncology Reports Fourth Quarter and Full Year 2023 Financial Results

– Positive preliminary combination data from KOMET-007 trial of ziftomenib in NPM1-m and KMT2A-r AML, including effective mitigation of differentiation syndrome – – First patient dosed in. ....

Troy Wilson , Alexandra Weingarten , Exchange Commission , Globenewswire Inc , Investor Relations Corporate Communications , Kura Oncology Inc , Chief Executive Officer , Lymphoma Society , Pediatric Acute Leukemia , Master Clinical , Mirati Therapeutics , Operations Data , Vice President , Investor Relations ,

Kura Oncology Reports Positive Preliminary Ziftomenib Combination Data in Acute Myeloid Leukemia

Kura Oncology Reports Positive Preliminary Ziftomenib Combination Data in Acute Myeloid Leukemia
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Troy Wilson , Alexandra Weingarten , Samer Zeidan , Company Form , Kura Oncology Inc , Investor Relations Corporate Communications , Drug Administration , Corporate Communications , Exchange Commission , Division Of Hematologic Malignancies , Hematologic Malignancies , Hematology Early Therapeutics Research , Yale Cancer Center , Chief Executive Officer , Orphan Drug Designation , Pete De Spain , Executive Vice President , Investor Relations , Associate Director , European Leukemianet , Kura Oncology ,

Kura Oncology's Menin Inhibitor Ziftomenib Selected for The Leukemia & Lymphoma Society's Pediatric Acute Leukemia (PedAL) Master Clinical Trial -December 08, 2023 at 07:30 am EST

SAN DIEGO, Dec. 08, 2023 Kura Oncology, Inc. , a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, and The Leukemia. ....

United States , New Zealand , Ryan Mcdonald , Gwen Nichols , Alexandra Weingarten , Mollie Leoni , Clinical Development , Kura Oncology Inc , Corporate Communications , Fast Company , Leukemia Lymphoma Society , Globenewswire Inc , Information Resource Center , Science Communications , Exchange Commission , Drug Administration , Lymphoma Society , Executive Vice President , Pediatric Oncology , Pediatric Acute Leukemia , Chief Medical Officer , Orphan Drug Designation , Pediatric Acute Leukemia Master Trial , Screening Trial , Resource Center , That Matter ,